Environmental triggers of type 1 diabetes

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 7, 2012, Pages

  Knip, Mikael ^a,b,c   Simell, Olli ^d  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b FOLKHÄLSAN RESEARCH CENTER   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD20 ANTIBODY; CHEMOKINE; CYTOKINE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; GLUTEN; HLA DQB1 ANTIGEN; ICOSANOID; INSULIN ANTIBODY; MILK PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; OMEGA 3 FATTY ACID; PANCREAS ISLET CELL ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; PROTEIN VP7; VITAMIN D; ZINC TRANSPORTER; INSULIN;

ARTICLE; CELIAC DISEASE; CELL DESTRUCTION; CELL MEMBRANE PERMEABILITY; CELLULAR IMMUNITY; COXSACKIE VIRUS INFECTION; DIETARY COMPLIANCE; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; GROWTH; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MICROBIAL CONSORTIUM; MICROBIAL DIVERSITY; MICROBIOME; MUCOSAL IMMUNITY; NONHUMAN; ROTAVIRUS INFECTION; SEROCONVERSION; WEIGHT GAIN; AUTOIMMUNITY; BACTERIAL INFECTION; BREAST FEEDING; DIET; ENTEROVIRUS INFECTION; GENETIC PREDISPOSITION; IMMUNOLOGY; PANCREAS ISLET; REVIEW; VITAMIN D DEFICIENCY;

ENTEROVIRUS;

AUTOIMMUNITY; BACTERIAL INFECTIONS; BREAST FEEDING; DIABETES MELLITUS, TYPE 1; DIET; ENTEROVIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; ISLETS OF LANGERHANS; VITAMIN D DEFICIENCY;

EID: 84870936276     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a007690     Document Type: Article

References (91)

1. Åkerblom HK, Vaarala O, Hyöty H, Ilonen J, Knip M. 2002. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 115: 18-29.
2. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341.
3. Barnett AH, Eff C, Leslie RDG, Pyke DA. 1981. Diabetes in identical twins. A study of 200 pairs. Diabetologia 20: 87-93.
4. Blomquist M, Juhela S, Erkkilä S, Korhonen S, Simell T, Kupila A, Vaarala O, Simell O, Knip M, Ilonen J. 2002. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. Clin Exp Immunol 128: 511-515.
5. Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, Casella G, Drew JC, Ilonen J, Knip M, et al. 2011. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 6: e25792.
6. Chase HP, Lescheck R, Rafkin-Mervis L, Krause-Steinrauf H, Chritton S, AsareS, Adams S, Skyler JS, Clare-Salzier M, Type 1 Diabetes Trialnet NIP Study Group. 2009. Nutritional intervention to prevent (NIP) type 1 diabetes: A pilot trial. Infant Child Adolesc Nutr 1: 99-107.
7. Dahlquist GG, Blom L, Persson LÅ, Sandström AI, Wall SG. 1990. Dietary factors and the risk of developing insulin dependent diabetes in childhood. Br Med J 300: 1302-1306.
8. Fuchtenbusch M, Irnstetter A, Jager G, Ziegler AG. 2001. No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun 17: 333-340.
9. Gillespie KM, Bain SC, Barnett AH, Bingley PJ, Christie MR, Gill GV, Gale EA. 2004. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364: 1699-1700.
10. Giongo A, Mukherjee N, Gano KA, Crabb DB, Casella G, Drew JC, Ilonen J, KnipM, Hyöty H, Veijola R, et al. 2011. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 5: 82-91.
11. Graves PM, Rotbart HA, Nix WA, Pallansch MA, Erlich HA, Norris JM, HoffmanM, Eisenbarth GS, Rewers M. 2003. Prospective study of enteroviral infections and development of β-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res Clin Pract 59: 51-61.
12. Hermann R, Knip M, Veijola R, Simell O, Laine AP, Åkerblom HK, Groop PH, Forsblom C, Petterson-Fernholm K, Ilonen J, et al. 2003. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes-indication of an increased environmental pressure? Diabetologia 46: 420-425.
13. Hindmarsh PC, Matthews DR, Di Silvio L, Kurz AB, Brook CG. 1988. Relation between height velocity and fasting insulin concentrations. Arch Dis Child 63: 665-666.
14. Holmberg H, Wahlberg J, Vaarala O, Ludvigsson J, the ABIS studygroup. 2007. Short duration of breast-feeding as a risk factor for β-cell autoantibodies in 5-year-old children from the general population. Br J Nutr 97: 111-116.
15. Honeyman MC, Stone NL, Harrison LC. 1998. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: Potential for mimicry with rotavirus and other environmental agents. Mol Med 4: 231-239.
16. Honeyman MC, Coulson BS, Stone NL, Gellert SA, Goldwater PN, Steele CE, Couper JJ, Tait BD, Colman PG, Harrison LC. 1999. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49: 1319-1324.
17. Honeyman MC, Stone NL, Falk BA, Nepom G, Harrison LC. 2010. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol 184: 2204-2210.
18. Hummel M, Bonifacio E, Naserke HE, Ziegler AG. 2002. Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects. Diabetes Care 25: 1111-1116.
19. Hummel S, Pflüger M, Hummel M, Bonifacio E, Ziegler AG. 2011. Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: The BABYDIET study. Diabetes Care 34: 1301-1305.
20. Hyöty H, Taylor KW. 2002. The role of viruses in human diabetes. Diabetologia 45: 1353-1361.
21. Hyppönen E, Kenward MG, Virtanen SM, Piitulainen A, Virta-Autio P, Knip M, Åkerblom HK, the Childhood Diabetes in Finland Study Group. 1999. Infant feeding, early weight gain and risk of type 1 diabetes. Diabetes Care 22: 1961-1965.
22. Hyppönen E, Virtanen SM, Kenward MG, Knip M, Åkerblom HK, the Childhood Diabetes in Finland Study Group. 2000. Obesity, increased linear growth and risk of type 1 diabetes mellitus in children. Diabetes Care 23: 1755-1760.
23. Hyppönen E, Läärä E, Järvelin MR, Virtanen SM. 2001. Intake of vitamin D and risk of type 1 diabetes: A birth cohort study. Lancet 358: 1500-1504.
24. Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengård J, Kesäniemi YA. 1992. Concordance for Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35: 1060-1067.
25. Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM. 2004. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci 101: 4175-4179.
26. Kimpimäki T, Kupila A, Hämäläinen A-M, Kukko M, Kulmala P, Savola K, SimellT, Muona P, Ilonen J, Simell O, et al. 2001a. The first signs of ß-cell autoimmunity appear in infancy in genetically susceptible children from the general population: The Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab 86: 4782-4788.
27. Kimpimäki T, Erkkola M, Korhonen S, Kupila A, Virtanen SM, Ilonen J, Simell O, Knip M. 2001b. Short exclusive breast-feeding predisposes young children with increased genetic risk of type 1 diabetes to progressive β-cell autoimmunity. Diabetologia 44: 63-69.
28. Knip M. 2011. Pathogenesis of type 1 diabetes: Implications for incidence trends. Horm Res 76: 57-64.
29. Knip M, Hyöty H. 2008. Environmental determinants: The role of viruses and standard of hygiene. In Epidemiology of Pediatric and Adolescent Diabetes (ed. Dabelea D, Klingensmith GJ), pp. 63-64. Informa Healthcare, New York.
30. Knip M, Siljander H. 2008. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7: 550-557.
31. Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Åkerblom HK. 2005. Environmental triggers and determinants of β-cell autoimmunity and type 1 diabetes. Diabetes 54: S125-S136.
32. Knip M, Korhonen S, Kulmala P, Veijola R, Reunanen A, Raitakari OT, Viikari J, Åkerblom HK. 2010a. Prediction of type 1 diabetes in the general population. Diabetes Care 33: 1206-1212.
33. Knip M, Virtanen SM, Åkerblom HK. 2010b. Infant feeding and risk of type 1 diabetes. Am J Clin Nutr 91: 1506S-1513S.
34. Knip M, Virtanen SM, Seppä K, Ilonen J, Savilahti E, Vaarala O, Reunanen A, Teramo K, Hämäläinen AM, Paronen J, et al. 2010c. Dietary intervention in infancy and later signs of β-cell autoimmunity. N Engl J Med 363: 1900-1908.
35. Kondrashova A, Reunanen A, Romanov A, Karvonen A, Viskari H, Vesikari T, Ilonen J, Knip M, Hyöty H. 2005. A sixfold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med 37: 67-72.
36. Kostraba JN, Cruickshanks KJ, Lawler-Heavner J, Jobim LF, Rewers MJ, Gay EC, Chase HP, Klingensmith G, Hamman RF. 1993. Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes 42: 288-295.
37. Kukko M, Virtanen SM, Toivonen A, Erkkilä S, Korhonen S, Ilonen J, Simell O, Knip M. 2004. Geographic variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of β-cell autoimmunity within a high incidence country. Diabetes Care 27: 676-681.
38. Kukko M, Kimpimäki T, Korhonen S, Kupila A, Simell S, Veijola R, Simell T, Ilonen J, Simell O, Knip M. 2005. Dynamics of diabetes-associated autoantibodies in young children with HLA-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 90: 2712-2717.
39. Lamb MM, Yin X, Barriga K, Hoffman MR, Barón AE, Eisenbarth GS, Rewers M, Norris JM. 2008. Dietary glycemic index, development of islet autoimmunity, and subsequent progression to type 1 diabetes in young children. J Clin Endocrinol Metab 93: 3936-3942.
40. Lamb MM, Yin X, Zerbe GO, Klingensmith GJ, Dabelea D, Fingerlin TE, RewersM, Norris JM. 2009. Height growth velocity, islet autoimmunity and type 1 diabetes development: The Diabetes Autoimmunity Study in the Young. Diabetologia 52: 2064-2071.
41. Lempainen J, Vaarala O, Mäkelä M, Veijola R, Simell O, Knip M, Hermann R, Ilonen J. 2009. Interplay between genetic and dietary factors in type 1 diabetes. J Autoimmun 33: 155-163.
42. Lempainen J, Tauriainen S, Vaarala O, Mäkelä M, Honkanen H, Marttila J, Veijola R, Simell O, Hyöty H, Knip M, et al. 2012. Interaction of enterovirus infection and cow's milk based formula nutrition in type 1 diabetes-associated autoimmunity. Diabetes Metab Res Rev 28: 177-185.
43. Lipponen K, Gombos Z, Kiviniemi M, Siljander H, Hermann R, Veijola R, SimellO, Knip M, Ilonen J. 2010. Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes. Diabetes 59: 3253-3256.
44. Lönnrot M, Korpela K, Knip M, Ilonen J, Simell O, Korhonen S, Savola K, MuonaP, Simell T, Koskela P, et al. 2000. Enterovirus infection as a risk factor for ß-cell autoimmunity in a prospectively observed birth cohort-The Finnish Diabetes Prediction and Prevention (DIPP) Study. Diabetes 49: 1314-1318.
45. Mrena S, Savola K, Kulmala P, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group. 2003. Natural course of preclinical Type 1 diabetes in siblings of affected children. Acta Paediatr 92: 1403-1410.
46. Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich HA, Rewers M. 2003. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 290: 1713-1720.
47. Norris JM, Yin X, Lamb MM, Barriga K, Seifert J, Hoffman M, Orton HD, BarónAE, Clare-Salzler M, Chase HP, et al. 2007. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA 298: 1420-1428.
48. Oikarinen S, Martiskainen M, Tauriainen S, Huhtala H, Ilonen J, Veijola R, Simell O, Knip M, Hyöty H. 2011. Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 60: 276-279.
49. Orešič M, Simell S, Sysi-Aho M, Nänto-Salonen K, Seppänen-Laakso T, ParikkaV, Mattila I, Keskinen P, Katajamaa M, Yetukuri L, et al. 2008. Dysregulation of lipid and amino acid metabolism precedes autoimmunity in children who later progress to type 1 diabetes. J Exp Med 205: 2975-2984.
50. Palmer JP, Helquist S, Spinas GA, Mølvig J, Mandrup-Poulsen T, Andersen HU, Nerup J. 1989. Interaction of β-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 38: 1211-1216.
51. Parikka V, Näntö-Salonen K, Saarinen M, Simell T, Ilonen J, Hyöty H, Veijola R, Knip M, Simell O. 2012. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia doi: 10. 1007/s00125-012-2523-3.
52. Pastore MR, Bazzigaluppi E, Belloni C, Arcovio C, Bonifacio E, Bosi E. 2003. Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab 88: 162-165.
53. Peng H, Hagopian W. 2006. Environmental factors in the development of Type 1 diabetes. Rev Endocr Metab Disord 7: 149-162.
54. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, McGee PF, Moran AM, et al. 2009. Rituximab, B-lymphocyte depletion, and preservation of β-cell function. N Engl J Med 361: 2143-2152.
55. Pflueger M, Seppänen-Laakso T, Suortti T, Hyötyläinen T, Achenbach P, Bonifacio E, Oresic M, Ziegler AG. 2011. Age-and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes 60: 2740-2747.
56. Pociot F, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G, Nierras CR, Todd JA, Rich S, Nerup J. 2010. Genetics of type 1 diabetes: What's next?Diabetes 59: 1561-1571.
57. Räsänen M, Kronberg-Kippilä C, Ahonen S, Uusitalo L, Kautiainen S, Erkkola M, Veijola R, Knip M, Kaila M, Virtanen SM. 2006. Intake of vitamin D by Finnish children aged 3 months to 3 years in relation to sociodemographic factors. Eur J Clin Nutr 60: 1317-1322.
58. Sabbah E, Savola K, Ebeling T, Kulmala P, Vähäsalo P, Salmela P, Knip M. 2000. Genetic, autoimmune, and clinical characteristics of childhood-and adult-onset Type 1 diabetes mellitus. Diabetes Care 23: 1326-1332.
59. Siljander H, Simell S, Hekkala A, Lähde J, Simell T, Vähäsalo P, Veijola R, IlonenJ, Simell O, Knip M. 2009. Predictive value of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility recruited from the general population. Diabetes 58: 2835-2842.
60. Simonen-Tikka ML, Pflueger M, Klemola P, Savolainen-Kopra C, Smura T, Hummel S, Kaijalainen S, Nuutila K, Natri O, Roivainen M, et al. 2011. Human enterovirus infections in children at increased risk for type 1 diabetes: The Babydiet study. Diabetologia 54: 2995-3002.
61. Simpson M, Brady H, Yin X, Seifert J, Barriga K, Hoffman M, Bugawan T, BarónAE, Sokol RJ, Eisenbarth G, et al. 2011. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: The Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 54: 2779-2788.
62. Stene LC, Joner G, Norwegian Childhood Diabetes Study Group. 2003. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: A large, population-based, case-control study. Am J Clin Nutr 78: 1128-1134.
63. Stene LC, Thorsby PM, Berg JP, Rønningen KS, Joner G, Norwegian Childhood Diabetes Study Group. 2008. Peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism, cod liver oil and risk of type 1 diabetes. Pediatr Diabetes 9: 40-45.
64. Stene LC, Oikarinen S, Hyöty H, Barriga KJ, Norris JM, Klingensmith G, HuttonJC, Erlich HA, Eisenbarth GS, Rewers M. 2010. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: The Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 39: 3174-3180.
65. Streng J. 1946. Over de beoordeling van de voedingstoestand in de praktijk (in Dutch, summary in English). Maandschrift v Kindergen 14: 67-78.
66. Sysi-Aho M, Ermolov A, Tripathi A, Seppänen-Laakso T, Ruohonen ST, Toukola L, Yetukuri L, Härkönen T, Lindfors E, Nikkilä J, et al. 2011. Metabolic regulation in progression to autoimmune diabetes. PLoS Comput Biol 7: e1002257.
67. Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H. 2011. Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol 33: 45-55.
68. The EURODIAB ACE Study Group and The EURODIAB ACE Substudy 2 Study Group. 1998. Familial risk of Type I diabetes in European children. Diabetologia 41: 1151-1156.
69. The EURODIAB ACE Study Group. 2000. Variation and trends in incidence of childhood diabetes in Europe. Lancet 355: 873-876.
70. The EURODIAB Substudy 2 Study Group. 1999. Vitamin D supplement in early childhood and risk of Type I (insulin-dependent) diabetes mellitus. Diabetologia 42: 51-54.
71. The EURODIAB Substudy 2 Study Group. 2001. Rapid early growth is associated with increased risk of childhood type 1 diabetes in various European populations. Diabetes Care 25: 1755-1760.
72. The TRIGR Study Group. 2011. The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: Recruitment, intervention and follow-up. Diabetologia 54: 627-633.
73. Vaarala O, Knip M, Paronen J, Hämäläinen A-M, Muona P, Väätäinen M, IlonenJ, Simell O, Åkerblom HK. 1999. Cow milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 48: 1389-1394.
74. Vaarala O, Atkinson MA, Neu J. 2008. The "perfect storm" for type 1 diabetes: The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57: 2555-2562.
75. Vaarala O, Ilonen J, Ruohtula T, Pesola J, Virtanen SM, Härkönen T, Koski M, Kallioinen H, Tossavainen O, Poussa T, et al. 2012. Removal of bovine insulin from cow's milk formula and early initiation of β-cell autoimmunity. Arch Pediat Adol Med doi: 10. 1001/archpediatrics. 2011. 1559.
76. Verge CF, Howard NJ, Irwig L, Simpson JM, Mackerras D, Silink M. 1994. Environmental factors in childhood IDDM: A population-based case-control study. Diabetes Care 17: 1381-1389.
77. Virtanen SM, Knip M. 2003. Nutritional risk predictors of β cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr 78: 1053-1067.
78. Virtanen SM, Räsänen L, Aro A, Lindström J, Sippola H, Lounamaa R, ToivanenL, Tuomilehto J, Akerblom HK. 1991. Infant feeding in Finnish children <7 yr of age with newly diagnosed IDDM. Diabetes Care 14: 415-417.
79. Virtanen SM, Räsänen L, Ylönen K, Aro A, Clayton D, Langholz B, Pitkäniemi J, Savilahti E, Lounamaa R, Tuomilehto J, et al. 1993. Early introduction of dairy products associated with increased risk of IDDM in Finnish children. Diabetes 42: 1786-1790.
80. Virtanen SM, Hyppönen E, Läärä E, Vähäsalo P, Kulmala P, Savola K, Räsänen L, Knip M, Åkerblom HK, the Childhood Diabetes in Finland Study Group. 1998. Cow's milk consumption, disease associated autoantibodies and Type 1 diabetes mellitus: A follow-up study in siblings of diabetic children. Diabetic Med 15: 730-738.
81. Virtanen SM, Kenward MG, Erkkola M, Kautiainen S, Kronberg-Kippilä C, Hakulinen T, Ahonen S, Uusitalo L, Veijola R, Simell OG, et al. 2006. Age at introduction of new foods and advanced β-cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 49: 1512-1521.
82. Virtanen SM, Nevalainen J, Kronberg-Kippilä C, Ahonen S, Tapanainen H, Uusitalo L, Takkinen HM, Niinistö S, Ovaskainen M-L, Kenward MG, et al. 2012. Food consumption during childhood and advanced β-cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes: A nested case-control study. Am J Clin Nutr 95: 471-478.
83. Viskari H, Kondrashova A, Koskela P, Knip M, Hyöty H. 2006. Circulating vitamin D concentrations in two neighboring populations with markedly different incidence of type 1 diabetes. Diabetes Care 49: 1458-1459.
84. Wadsworth EJK, Shield JPH, Hunt LP, Baum JD. 1997. A case-control study of environmental factors associated with diabetes in the under 5s. Diabet Med 14: 390-396.
85. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, et al. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113.
86. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, EisenbarthGS, Jensen J, Davidson HW, et al. 2007. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci 104: 17040-17045.
87. Wilkin TJ. 2001. The accelerator hypothesis: Weight gain as the missing link between type 1 and type 2 diabetes. Diabetologia 44: 914-922.
88. Yeung WC, Rawlinson WD, Craig M. 2011. Enterovirus infection and type 1 diabetes mellitus: Systematic review and meta-analysis of observational molecular studies. BMJ 342: d35.
89. Ziegler A-G, Hummel M, Schenker M, Bonifacio E. 1999. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABYDIAB Study. Diabetes 48: 460-468.
90. Ziegler A-G, Schmid S, Huber D, Hummel M, Bonifacio E. 2003. Early infant feeding and risk of developing Type 1 diabetes-associated autoantibodies. JAMA290: 1721-1728.
91. Zipitis CS, Akobeng AK. 2008. Vitamin D supplementation in early childhood and risk of type 1 diabetes: A systematic review and meta-analysis. Arch Dis Childr 93: 512-517.